| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 39.240 | 51.716 | 74.070 | 86.926 | 102.775 | 75.092 | 77.643 | 85.953 | 83.466 | 75.047 |
| Total Income - EUR | 39.415 | 51.809 | 74.073 | 86.937 | 102.789 | 75.223 | 78.134 | 85.973 | 84.821 | 75.227 |
| Total Expenses - EUR | 29.880 | 50.163 | 66.040 | 82.568 | 72.220 | 58.689 | 56.907 | 57.274 | 84.725 | 64.324 |
| Gross Profit/Loss - EUR | 9.535 | 1.646 | 8.033 | 4.370 | 30.569 | 16.534 | 21.227 | 28.699 | 96 | 10.903 |
| Net Profit/Loss - EUR | 8.350 | 1.128 | 7.292 | 3.500 | 29.541 | 15.936 | 20.445 | 27.857 | -735 | 8.691 |
| Employees | 1 | 2 | 4 | 6 | 4 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Syromed Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.089 | 24.668 | 19.710 | 14.891 | 11.498 | 7.487 | 22.765 | 19.640 | 16.281 | 12.566 |
| Current Assets | 9.480 | 1.851 | 9.760 | 16.588 | 32.753 | 37.497 | 26.019 | 45.617 | 19.761 | 26.537 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 82 | 46 | 112 | 13 | 312 | 382 | 238 | 776 | 503 |
| Cash | 9.480 | 1.769 | 9.714 | 16.476 | 32.740 | 37.185 | 25.637 | 45.379 | 18.984 | 26.033 |
| Shareholders Funds | 17.804 | 18.750 | 25.725 | 28.753 | 41.767 | 45.265 | 52.960 | 67.917 | 40.553 | 40.583 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 2.855 | 7.953 | 4.030 | 3.063 | 2.960 | 208 | 1.137 | 1.759 | 760 | 2.569 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Syromed Plus Srl